Your browser doesn't support javascript.
loading
Alzheimer's disease seeded tau forms paired helical filaments yet lacks seeding potential.
Duan, Pu; Dregni, Aurelio J; Xu, Hong; Changolkar, Lakshmi; Lee, Virginia M-Y; Lee, Edward B; Hong, Mei.
Affiliation
  • Duan P; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Dregni AJ; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Xu H; Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Changolkar L; Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Lee VM; Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Lee EB; Translational Neuropathology Research Laboratory, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Pennsylvania, USA.
  • Hong M; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. Electronic address: meihong@mit.edu.
J Biol Chem ; 300(9): 107730, 2024 Sep.
Article in En | MEDLINE | ID: mdl-39214304
ABSTRACT
Alzheimer's disease (AD) and many other neurodegenerative diseases are characterized by pathological aggregation of the protein tau. These tau aggregates spread in a stereotypical spatiotemporal pattern in the brain of each disease, suggesting that the misfolded tau can recruit soluble monomers to adopt the same pathological structure. To investigate whether recruited tau indeed adopts the same structure and properties as the original seed, here we template recombinant full-length 0N3R tau, 0N4R tau, and an equimolar mixture of the two using sarkosyl-insoluble tau extracted from AD brain and determine the structures of the resulting fibrils using cryoelectron microscopy. We show that these cell-free amplified tau fibrils adopt the same molecular structure as the AD paired-helical filament (PHF) tau but are unable to template additional monomers. Therefore, the PHF structure alone is insufficient for defining the pathological properties of AD tau, and other biochemical components such as tau posttranslational modifications, other proteins, polyanionic cofactors, and salt are required for the prion-like serial propagation of tauopathies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tau Proteins / Alzheimer Disease Limits: Humans Language: En Journal: J Biol Chem Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tau Proteins / Alzheimer Disease Limits: Humans Language: En Journal: J Biol Chem Year: 2024 Type: Article Affiliation country: United States